Abirakast Tablet

Abiraterone Acetate is the active ingredient in Abirakast.

Abirakast 250 mg are manufactured by BDR Pharmaceuticals Pvt Ltd. and branded by Aprazer Healthcare Pvt Ltd.

Yes, It has to be consumed only with a proper doctor’s prescription.

The Abiraterone Acetate in Abirakast reduces the production of androgen, which promotes the growth of tumors in the body. It is recommended for patients whose prostate cancer cannot be treated through surgical or other pharmaceutical interventions.

Abiraterone Acetate in Abirakast checks prostate cancer progression increases life span and delays common symptoms like tiredness and pain.

It is prescribed to be used with prednisone or prednisolone. This depends on the cancer treatment received by the patients.

It is used in combination with prednisone for patients with prostate cancer who are resistant to metastatic castration and have received docetaxel-containing chemotherapy treatment.

A combination of prednisone or prednisolone and Abirakast is prescribed for adult men with prostate cancer resistant to metastatic castration but are mildly symptomatic or asymptomatic after androgen deprivation therapy has failed and for whom clinical chemotherapy has not been prescribed.

When used with prednisone, Abirakast reduces hypertension as a possible side-effect and reduces antigens’ production that stimulates prostate cancer.

It must be administered orally daily in 1000mg dosages on four tablets of 250 mg and be taken on an empty stomach. This means the Abirakast administration has to be done with an empty stomach, either two hours after meals or one hour before meals. 10mg prednisone will be administered along with Abirakast tablets, and the drug has to be taken at the same time daily.

The most likely side-effects of consuming Abirakast include unwanted swelling, muscular and joint discomfort, and stomach problems like vomiting, diarrhea, and indigestion. It may cause other side effects like shortness of breath or upper respiratory tract infection, enduring hot flush or feeling uncomfortably hot, and illness in the urinary tract.

Patients may rarely have irregular heartbeats, cannot urinate for over eight hours, have difficulty breathing, or a fever of 100.4°F with chills. If patients exhibit any of these symptoms after intaking this tablet, medical assistance must be sought at the earliest.

Suppose the patient has a severe headache, dizziness, extreme fatigue, unusual spike in blood pressure, yellowing of skin and eyes, blood in stools, diarrhea, or unusual bleeding. In that case, medical assistance has to be sought, though they are not life-threatening.

Patients who had heart conditions or liver complications that can cause hepatoxicity or increased production of unwanted liver proteins should be cautious and seek the doctor’s help before consuming it.

Patients should get their blood tested every month if they suffer from hypertension or arrhythmia while intaking this tablet. They should take corticosteroid drugs like prednisone, which is used in combination with Abirakast if they suffer from stress or due to the non-production of water-retaining and potassium-producing steroids.

The recommended daily dosage of Abirakast is 1000 mg or four tablets with a dosage of 250mg.

No side effects were found during clinical studies of Abirakast overdosage. However, patients who had an overdosage of it should undertake general supportive measures like monitoring for heart and liver failure.

Laboratory side-effects of this tablet intake include low levels of potassium and phosphorous, weakness due to amnesia or the lack of hemoglobin in the blood, and high levels of cholesterol, fat molecules, and sugars.

It cannot be prescribed for children.

It can be prescribed for pregnant women. However, they should stay away from the drug during pregnancy. Suppose the patient is using the medicine during pregnancy or becomes pregnant during the course. In that case, she should be made aware of the drug’s potential risks.

Nursing women are advised to avoid the drug as there are high potentials of severe reactions of Abirakast in nursing children.

Patients with mild hepatic impairment and renal impairment do not require any dose adjustment. However, patients with moderate hepatic impairment should restrict the daily dosage to one tablet. The drug has to be avoided entirely by patients with severe hepatic impairment.

Yes, It is safe for geriatric use.

The tablets should be ideally stored at room temperature and should not be exposed to heat or light. However, the tablets should not be stored in a freezer.

A packet of Abirakast tablets has a shelf life of three years. However, customers must check out the expiration date on the back of the cover. The expiration date is the last day of the month mentioned, and customers should not use the tablets beyond that date.

These tablets are packed in an HDPE container containing 120 tablets. These containers are packed in a mono carton and a pack insert.

It can be purchased directly from the manufacturers without the need for intermediaries. The suppliers follow strict regulations during the procurement of the drug. Only “fresh-batch” consignments are supplied.